To maximize the effect, these injections are often used together with a healthy diet and regular exercise
Prevalence of GLP-1 medication exposure prior to, during, and after pregnancy using state-wide data from 2017 to 2023
Mounjaro and Wegovy can only be prescribed to patients with a BMI of 30 or higher, or those with a BMI of 27 or higher who have at least one obesity-related condition such as hypertension or diabetes
Common Side Effects Nausea (usually improves after 2-4 weeks) Diarrhea or constipation Decreased appetite (the intended effect) Mild stomach discomfort Fatigue during dose increases When to Call Your Doctor Severe or persistent nausea/vomiting Signs of pancreatitis (severe abdominal pain) Vision changes Rapid heartbeat Signs of allergic reaction Keller Semaglutide FAQs No
Remove the drug, remove the effect, essentially
Such conjugates avoid E2 release in circulation and maximize E2 release in target cells